
We Love the Samsung Galaxy Z Flip 5 and It's Down to an All-Time Low of $776 at Amazon
This phone is currently out of stock at Samsung itself, as they're now promoting the Flip 6 and their latest, the Flip 7. Though the Samsung Galaxy Z Flip 5 is a previous release, it's still one of our picks for the best foldable phones you can buy today, and the current discount saves you a massive $324 on its list price. It's worth taking advantage of this offer if you need a new phone and want to avoid potential price increases due to tariffs.
During our Samsung Galaxy Z Flip 5 review, CNET phone expert Lisa Eadicicco found that the "big cover screen is fun to use" and it has a "solid battery life." One of the few cons noted was how expensive the phone is, however, this discount makes it much more palatable.
If you're okay with an open-box phone instead of one that's completely new, select Best Buy stores are also offering the Flip 5 for as low as $560 (256GB) or $594 for the 512GB configuration. Keep in mind that open-box phones from Best Buy might have minor signs of wear and tear, as these phones were on display. Some of these imperfections might include scratches, lack of nonessential parts and may not include original packaging. Best Buy restores all of its open-box phones to factory settings, and all software and functions work properly.
Hey, did you know? CNET Deals texts are free, easy and save you money.
Keep in mind that although Best Buy has steeper discounts, Amazon's trade-in program knocks off up to $725, which could result in larger savings overall.
Not keen on this deal? Here's our guide on the best phones to buy in 2025 ranging from Apple to Samsung, Google and more.
Why this deal matters
The Samsung Galaxy Z Flip 5 is still a fantastic phone if you're open to getting a previously released model. Though it's getting harder to find these, both Amazon and Best Buy are offering major discounts on the Galaxy Z Flip 5. On top of their discounts, both retailers offer trade-in benefits that could help you save even more on their current record-low offers.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Bloomberg
a minute ago
- Bloomberg
Musk Says xAI Will Make Kid-Friendly App Called Baby Grok
Elon Musk says his artificial intelligence startup will make an app dedicated to kid-friendly content and call it Baby Grok. The billionaire didn't provide further details on Baby Grok in a post on X.

Wall Street Journal
7 minutes ago
- Wall Street Journal
Charles Schwab Stock Hits First Record Since 2022
Charles Schwab shares rose to their first record closing high since January 2022, powered by an earnings report that benefited from heavy trading activity. The company joined other banks and brokers in enjoying a busy and volatile spring marked by investors' reaction to President Trump's ongoing trade war. Schwab stock closed at $95.80, up 2.9% on the day. The stock hit its previous closing high of $95.53 on Jan. 14. 2022, according to Dow Jones Market Data.
Yahoo
29 minutes ago
- Yahoo
Medpace (MEDP) Q2 Earnings Report Preview: What To Look For
Clinical research company Medpace Holdings (NASDAQ:MEDP) will be reporting results this Monday after market hours. Here's what to expect. Medpace beat analysts' revenue expectations by 6% last quarter, reporting revenues of $558.6 million, up 9.3% year on year. It was an exceptional quarter for the company, with an impressive beat of analysts' organic revenue estimates and an impressive beat of analysts' EPS estimates. Is Medpace a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Medpace's revenue to grow 2.6% year on year to $542 million, slowing from the 14.6% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $3.00 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Medpace has missed Wall Street's revenue estimates five times over the last two years. With Medpace being the first among its peers to report earnings this season, we don't have anywhere else to look to get a hint at how this quarter will unravel for life sciences tools & services stocks. However, the whole sector has been hit hard over the last month as stocks in Medpace's peer group are down 2.5% on average. Medpace's stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $301.61 (compared to the current share price of $311.86). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here. Sign in to access your portfolio